✦ LIBER ✦

Evaluation of Plasma Hormone Concentrations in Relation to Clinical Staging in Patients with Prostatic Cancer:BRITISH PROSTATE STUDY GROUP

Book ID: 115192336
Publisher: John Wiley and Sons
Year: 1979
Tongue: English
Weight: 635 KB
Volume: 51
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.1979.tb02891.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Kinetic analysis of prostatic volume in

Kinetic analysis of prostatic volume in patients with stage D prostatic cancer treated with LHRH analogues in relation to prognosis

✍ M. Kojima; H. Ohe; H. Watanabe 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB

Comparison of Hormonal Therapy and Chemo

Comparison of Hormonal Therapy and Chemohormonal Therapy in Patients with Newly Diagnosed Clinical Stage D Prostatic Cancer

✍ Hideaki Miyake; Isao Hara; Masato Fujisawa; Hiroshi Eto; Hiroshi Okada; Soichi A 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB

Prognostic significance of plasma chromo

Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study

✍ Mary-Ellen Taplin; Daniel J. George; Susan Halabi; Ben Sanford; Philip G. Febbo; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Changes in serum levels of prostatic aci

Changes in serum levels of prostatic acid phosphatase and prostate specific antigen after luteinizing hormone-releasing hormone analogue administration in patients with metastatic prostatic cancer in relation to glandular differentiation

✍ I. Sasagawa; T. Nakada; Y. Kubota; T. Sawamura; K. Izumiya 📂 Article 📅 1995 🏛 Springer Netherlands 🌐 English ⚖ 301 KB

Response of plasma fibrinogen and plasmi

Response of plasma fibrinogen and plasminogen to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer

✍ U. S. Seal; R. P. Doe; D. P. Byar; D. K. Corle 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 869 KB

Fibrinogen and plasminogen were measured in plasma samples from prostatic cancer patients before and after 3 months of treatment with either Premarin, Provera, Provera and diethylstilbestrol, one of three doses of diethylstilbestrol, o r placebo. Plasminogen levels generally were increased significa

MP-18.09: A Clinical Study of Carboplati

MP-18.09: A Clinical Study of Carboplatin plus Docetaxel in Patients with Metastatic Hormone-Refractory Prostate Cancer

✍ I. Go; T. Ito; K. Kuratsukuri; M. Matsuyama; S. Tamada; T. Tanaka; J. Uchida; R. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 151 KB